Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis
Clinical trial NCT05288179 · RECRUITING
Trial details
- NCT number
- NCT05288179
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-07
- Primary completion
- 2026-09-30
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.